{
    "nct_id": "NCT04374461",
    "official_title": "Phase II Study of N-acetylcysteine in Severe or Critically Ill Patients With Refractory COVID-19 Infection",
    "inclusion_criteria": "* Documented COVID-19 infection (either performed on site or documented external report)\n* Age ≥ 18\n\nArm A:\n\n* Admission to an intensive care unit at MSK (M-11) and/or receiving mechanical ventilation\n* Absolute lymphocyte count ≤ 1.0/mm3\n* As the ALC of patients with lymphoid malignancies is unreliable, they may be enrolled at the discretion of the treating physician after review of their blood work.\n\nArm B:\n\n* Arm B:Requiring 2L or more of supplemental oxygen by nasal cannula or higher to maintain SpO2 of 95%\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Arm B:\n\n* requiring mechanical ventilation or admission to an intensive care unit at MSK (M11)",
    "miscellaneous_criteria": ""
}